Corporate Banner
Satellite Banner
Genotyping & Gene Expression
Scientific Community
Become a Member | Sign in
Home>News>This Article

MolecularHUB Gives Scientific Information on Fast-moving Diseases

Published: Thursday, October 25, 2012
Last Updated: Thursday, October 25, 2012
Bookmark and Share
A scientific gateway website that will provide molecular and genetic information on infectious and emerging diseases has been released by Purdue University.

The MolecularHUB site was announced Wednesday (Oct. 24) at the annual meeting of the Association for Molecular Pathology (AMP), which is being held in Long Beach, Calif.

James McGlothlin, a Purdue associate professor of health sciences and director of the site, said MolecularHUB will actively foster an environment of co-creation and collaboration. The goal of the site is to expand the current knowledge base of genetic markers, gene sequencing and molecular testing related to infectious diseases, chronic diseases and emerging diseases to help speed the identification and treatment of these diseases.

"With this site we have the opportunity to improve public health care and patient outcomes by providing free, easy access to the latest information," McGlothlin said. "The half-life of information in this field is very short; it's one of the fastest moving disciplines in modern science. So this site will keep professionals up-to-date with the latest scientific information."

The site,, is exclusively sponsored by BD (Becton Dickinson and Company), a Fortune 500 medical supply company.

"The goal is involve anyone working with molecular diagnostics so we can combine and leverage resources and capabilities," McGlothlin said. "This will allow us to standardize work practices and provide training and programs that will enhance scientific knowledge in this field."

Gregory Meehan, vice president for diagnostic systems and molecular diagnostics at BD Diagnostics, one of three divisions of BD, said the site has the potential to bring together medical and scientific communities.

"The valuable information and experiences of the global laboratory, scientific and academic community will come together through MolecularHUB in developing and sharing best practices across the spectrum of molecular-based diagnostic applications, laboratory efficiency, and clinical and economic outcomes," Meehan said.

The site is built on the Purdue-developed platform HUBzero, which has been used by more than 40 scientific, engineering and medical gateway sites as resources for scientific communities.

"MolecularHUB will be accessible to the more than 600,000 visitors of other hubs each year," McGlothlin said. "This will foster other opportunities for synergistic collaborations among disciplines such as engineering, laboratory design and ergonomics, and drug delivery."

Further Information
Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 2,600+ scientific posters on ePosters
  • More than 3,800+ scientific videos on LabTube
  • 35 community eNewsletters

Sign In

Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.

Related Content

New Technique Yields Drug, Biomedical Test Results in One Minute
Slug flow microextraction makes it possible to quickly detect the presence of drugs or to monitor certain medical conditions using only a single drop of blood or urine.
Tuesday, October 14, 2014
Helping Genes Get Out of the Starting Blocks Faster
Yeast can quickly adapt to changes in its environment with the help of molecules known as long non-coding RNAs, a Purdue study shows.
Friday, February 21, 2014
Purdue Innovation could Improve Personalized Cancer-Care Outcomes
An innovation could improve therapy selection for personalized cancer care by helping specialists better identify the most effective drug treatment combinations for patients.
Friday, August 16, 2013
Purdue Researcher Invents Molecule that Stops SARS
A Purdue University researcher has created a compound that prevents replication of the virus that causes SARS and could lead to a treatment for the disease.
Tuesday, November 18, 2008
Researcher Hits Bulls-Eye for Antibiotic Target
Purdue researcher determines the structure of a protein that controls the starvation response of E. coli.
Wednesday, August 23, 2006
Purdue Scientists Treat Cancer with RNA Nanotechnology
Microscopic particles possess both the right size to gain entry into cells and also the right structure to carry other therapeutic strands of RNA inside with them.
Tuesday, September 20, 2005
Scientific News
Lung Repair and Regeneration Gene Discovered
New role for hedgehog gene offers better understanding of lung disease.
Mixed Up Cell Transportation Key Piece of ALS and Dementia Puzzle
Researchers from the University of Toronto are one step closer to solving this incredibly complex puzzle, offering hope for treatment.
Five New Genetic Variants Linked to Brain Cancer Identified
The biggest ever study of DNA from people with glioma – the most common form of brain cancer – has discovered five new genetic variants associated with the disease.
Predictive Model for Breast Cancer Progression
Biomedical engineers have demonstrated a proof-of-principle technique that could give women and their oncologists more personalized information to help them choose options for treating breast cancer.
New Hope for Personalized Treatment of Eczema
Pharmaceutical researchers at Oregon State University have developed a new approach to treat eczema and other inflammatory skin disorders that would use individual tests and advanced science to create personalized treatments based on each person's lipid deficiencies.
Gene Expression: A Snapshot of Stem Cell Development
New genes found that regulate development of stem cells.
Are Changes to Current Colorectal Cancer Screening Guidelines Required?
Editorial suggests more research is needed to pinpoint age to end aggressive screening.
Assessing Cancer Patient Survival and Drug Sensitivity
RNA editing events another way to investigate biomarkers and therapy targets.
New Molecular Marker for Killer Cells
Cell marker enables prognosis about the course of infections.
Genes That Protect African Children From Developing Malaria Identified
Variations in DNA at a specific location on the genome that protect African children from developing severe malaria, in some cases nearly halving a child’s chance of developing the life-threatening disease, have been identified in the largest genetic association study of malaria to date.
Skyscraper Banner

Skyscraper Banner
Go to LabTube
Go to eposters
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
2,600+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
3,800+ scientific videos